Corporate Social Responsibility (CSR), also known as corporate conscience, refers to a management idea that sees companies integrating social and environmental factors into their operations. CSR ...

Alex Johnston already has a statue at Rabbitohs headquarters in Maroubra but the greatest tryscorer in premiership history could create a more important legacy in Papua New Guinea. It’s why Johnston ...

Entering his final few weeks with Manchester United, Brazilian defensive midfielder Casemiro is surveying his options for the next step in his career and several MLS clubs are reportedly interested.

President Trump on Tuesday escalated his efforts to reshape American elections, signing an executive order that seeks to create lists of U.S. citizens who are eligible to vote in each state, and ...

The Washington Commanders have made a few moves on offense during free agency as they plan to recapture the success they had two seasons ago. The latest move they made was re-signing a key player from ...

The Washington Commanders weren’t done making moves in free agency, and by keeping up the hunt for the best available, have ended up solidifying a position that was 1 of their biggest weaknesses in ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...